Investment Firm
Overview
Earli is a developer of cancer treatment devices designed to search for natural biomarkers.
Jan 12, 2021
Series A
Highlights
Location
Social
Participant Investors
12
Earli raised $40000000 on 2021-01-12 in Series A
Earli is a developer of cancer treatment devices designed to search for natural biomarkers.
Company Funding History
3
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jun 22, 2018 | Pre Seed Round - Earli | 2 | - | 400.0K |
Sep 17, 2018 | Seed Round - Earli | 11 | - | 19.5M |
Jan 12, 2021 | Series A - Earli | 12 | - | 40.0M |
Recent Activity
There is no recent news or activity for this profile.